The appearance and
quick spread of the new severe acute respiratory
syndrome coronavirus disease, COVID-19, brought major societal challenges.
Importantly, suitable medical diagnosis procedures and smooth clinical
management of the disease are an emergent need, which must be anchored
on novel diagnostic methods and devices. Novel molecular diagnostic
tools relying on nucleic acid amplification testing have emerged globally
and are the current gold standard in COVID-19 diagnosis. However,
the need for widespread testing methodologies for fast, effective
testing in multiple epidemiological scenarios remains a crucial step
in the fight against the COVID-19 pandemic. Biosensors have previously
shown the potential for cost-effective and accessible diagnostics,
finding applications in settings where conventional, laboratorial
techniques may not be readily employed. Paper- and cellulose-based
biosensors can be particularly relevant in pandemic times, for the
renewability, possibility of mass production with sustainable methodologies,
and safe environmental disposal. In this review, paper-based devices
and platforms targeting SARS-CoV-2 are showcased and discussed, as
a means to achieve quick and low-cost PoC diagnosis, including detection
methodologies for viral genomic material, viral antigen detection,
and serological antibody testing. Devices targeting inflammatory markers
relevant for COVID-19 are also discussed, as fast, reliable bedside
diagnostic tools for patient treatment and follow-up.